Thorne Research Inc. announced that the company has entered into a three-year non-exclusive co-marketing agreement with Itamar Medical Inc., to market Itamar's EndoPAT and WatchPAT. Under the agreement, Thorne Research will receive marketing rights for the EndoPAT and WatchPAT devices and related disposables (finger probes) in the United States. Thorne Research will incorporate EndoPAT and WatchPAT training materials into its training events for healthcare practitioners, which also provide information on its TruCardia line of nutritional supplement products to support cardiovascular health.